🧫

IRI-AKI mouse model with mtROS inhibition

experiment Created: 2026-04-10 14:43:05 By: experiment_extractor Quality: 90% ✓ SciDEX ID: experiment-exp-7fb152da-1495-4cd3-bdf8-e
🧫 Experiment Protocol Animal Model
🧫 View Full Experiment Page →
Related Entities
TFAM
Metadata
experiment_typeanimal_model
protocolRenal ischemia-reperfusion surgery with or without mtROS inhibitor treatment, followed by analysis of renal function parameters, mitochondrial function markers, and inflammatory cytokines
expected_outcomesmtROS inhibition would attenuate renal dysfunction, mitochondrial damage, and inflammation
success_criteriaSignificant improvement in renal function parameters and reduction in mitochondrial damage and inflammation with mtROS inhibition
sample_sizeNone
statistical_methodsNone
p_valueNone
effect_sizeNone
extracted_at2026-04-10T07:43:05.743194
source_pmid33408785
_origin{'type': 'internal', 'url': None, 'tracked_at': '2026-04-10T14:43:05.745929'}
🌍 Provenance Graph 2 nodes, 1 edges

derives from (1)

Linked Artifacts (69)
derives_from📄Mitochondrial ROS promote mitochondrial dysfunction and infl100%
related🧫TFAM and mtDNA analysis in AKI patients100%
related🧫mtROS effects on TFAM and mtDNA in HK2 cells100%
related🧫TFAM knockdown functional analysis100%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr100%
mentions📖TFAM Gene80%
mentions📖TFAM Protein80%
related📖TFAM Gene72%
related📖TFAM Protein72%
mentions📖Mitochondria60%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr60%
related📓Nutrient-Sensing Epigenetic Circuit Reactivation — Computati60%
related📓Aging Mouse Brain Atlas: Cross-Age Gene Expression Analysis60%
related📖Mitochondria54%
mentions📖Section 194: Advanced Mitochondrial Dynamics and Biogenesis 50%
mentions📖Section 194: Advanced Mitochondrial Dynamics and Biogenesis 50%
mentions📖Mitochondrial Dysfunction Pathway in Neurodegeneration50%
mentions📖coq10-qe350%
mentions📖AMPK-Mitochondrial Quality Control Axis50%
mentions📖Lichen-derived Neuroprotective Compounds for Parkinson'50%
mentions📖Mitochondria in Neurodegeneration50%
mentions📖Mitochondrial Dysfunction in Neurodegeneration50%
mentions📖Mitochondrial Quality Control Network Pathway50%
mentions📖Neuroinflammation-Mitochondria Crosstalk Pathway50%
mentions📖NRF2 Oxidative Stress Pathway50%
mentions📖PGC-1α and Mitochondrial Biogenesis Therapies for Parkinson&50%
mentions📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration50%
mentions📖Mitochondrial Therapeutics50%
mentions📖NURR1 Agonist Therapy for Parkinson's Disease50%
mentions📖Insulin Signaling in Parkinson's Disease50%
mentions📖PGC-1α Mitochondrial Biogenesis Comparison — AD/PD/ALS/FTD/H50%
mentions📖Mitochondrial Biogenesis Inducers50%
mentions📖PGC-1α Activator Therapy for Neurodegeneration50%
mentions📖Mitochondrial DNA Replication50%
mentions📖Mitochondrial Dynamics in Neurodegeneration50%
mentions📖Mitochondrial Dysfunction Hub50%
mentions📖MitoPark Mouse Model50%
mentions📖cell-types44%
mentions📖Astrocytes44%
mentions📖Astrocytes in Amyotrophic Lateral Sclerosis44%
mentions📖Astrocytes in Argyrophilic Grain Disease44%
mentions📖Astrocytes in Hepatic Encephalopathy44%
mentions📖Astrocytes in Brain Homeostasis44%
mentions📖Astrocytes in Neurodegeneration44%
mentions📖Astrocytes in Parkinson's Disease Neurodegeneration44%
mentions📖Astrocytes in Wilson Disease44%
mentions📖Astrocytes in Dementia with Lewy Bodies44%
mentions📖Resilient Neurons in Alzheimer's Disease44%
mentions📖Mitochondrial Dynamics44%
mentions📖Exercise-BDNF-Mitochondrial Resilience Hypothesis44%
mentions📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&44%
mentions📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&44%
mentions📖Mitochondria-Lysosome Contact Sites (MLCS) in Neurodegenerat44%
mentions📖mitochondrial-dynamics44%
mentions📖mitochondrial-dysfunction-comparison44%
mentions📖Mitochondrial Quality Control44%
mentions📖Mitochondria-Lysosome Contact Sites in Parkinson's Dise44%
mentions📖NRF2-KEAP1 Oxidative Stress Response Pathway44%
mentions📖Mitochondrial Dysfunction in PD44%
mentions📖pink1-parkin-mitophagy-pd-causal-chain44%
mentions📖Transcriptional Regulation in Neurodegeneration44%
mentions📖Cytoskeletal Dynamics and Tubulin Targeting in CBS/PSP44%
mentions📖Mitochondrial Dynamics Modulators for Parkinson's Disea44%
mentions📖PGC-1α (PPARGC1A) Targeted Therapies in Neurodegeneration44%
mentions📖Phage Display and Directed Evolution for Tau Therapeutics44%
mentions📖Portable Exoskeleton for Parkinson's Disease Mobility (44%
mentions📖Section 244: Advanced Bioenergetics and ATP Restoration in C44%
mentions📖Supportive Care in Neurodegenerative Diseases44%
related📓Aging Mouse Brain Atlas: Cross-Age Gene Expression Analysis20%